News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
874,498 Results
Type
Article (88252)
Company Profile (812)
Press Release (785413)
Multimedia
Podcasts (211)
Webinars (32)
Section
Business (233371)
Career Advice (4152)
Deals (39900)
Drug Delivery (160)
Drug Development (91501)
Employer Resources (205)
FDA (18457)
Job Trends (17445)
News (398197)
Policy (40001)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3026)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (169)
Alliances (56982)
ALS (197)
Alzheimer's disease (1846)
Antibody-drug conjugate (ADC) (388)
Approvals (18656)
Artificial intelligence (699)
Autoimmune disease (221)
Automation (49)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (213)
Biotechnology (486)
Bladder cancer (180)
Brain cancer (71)
Breast cancer (711)
Cancer (5451)
Cardiovascular disease (484)
Career advice (3580)
Career pathing (44)
CAR-T (323)
CDC (68)
Celiac Disease (2)
Cell therapy (892)
Cervical cancer (42)
Clinical research (77587)
Collaboration (2001)
Company closure (6)
Compensation (1268)
Complete response letters (89)
COVID-19 (3009)
CRISPR (110)
C-suite (999)
Cystic fibrosis (157)
Data (6874)
Decentralized trials (2)
Denatured (78)
Depression (172)
Diabetes (574)
Diagnostics (7361)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (341)
Drug pricing (232)
Drug shortages (36)
Duchenne muscular dystrophy (279)
Earnings (100967)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136092)
Executive appointments (1089)
FDA (21893)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1674)
Gene editing (236)
Generative AI (72)
Gene therapy (738)
GLP-1 (1184)
Government (5491)
Grass and pollen (8)
Guidances (392)
Healthcare (20992)
HIV (77)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (313)
Immuno-oncology (81)
Indications (145)
Infectious disease (3342)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (275)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (101)
Layoffs (665)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (26)
Lung cancer (723)
Lymphoma (402)
Machine learning (50)
Management (66)
Manufacturing (968)
MASH (190)
Medical device (15113)
Medtech (15188)
Mergers & acquisitions (23067)
Metabolic disorders (1534)
mRNA (209)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (405)
Neuropsychiatric disorders (112)
Neuroscience (3313)
Neurotech (1)
NextGen: Class of 2026 (7712)
Non-profit (5127)
Now hiring (72)
Obesity (747)
Opinion (351)
Ovarian cancer (178)
Pain (238)
Pancreatic cancer (257)
Parkinson's disease (338)
Partnered (39)
Patents (562)
Patient recruitment (578)
Peanut (65)
People (67256)
Pharmaceutical (139)
Pharmacy benefit managers (34)
Phase 1 (23967)
Phase 2 (33672)
Phase 3 (25361)
Pipeline (6529)
Policy (366)
Postmarket research (3554)
Preclinical (10746)
Press Release (72)
Prostate cancer (280)
Psychedelics (61)
Radiopharmaceuticals (320)
Rare diseases (1060)
Real estate (7445)
Recruiting (81)
Regulatory (29466)
Reports (69)
Research institute (2749)
Resumes & cover letters (653)
Rett syndrome (32)
RNA editing (21)
RSV (92)
Schizophrenia (168)
Series A (283)
Series B (208)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (50)
Startups (4342)
State (2)
Stomach cancer (21)
Supply chain (124)
Tariffs (101)
The Weekly (130)
Vaccines (1202)
Venture capital (104)
Weight loss (510)
Women's health (110)
Worklife (23)
Date
Today (71)
Last 7 days (579)
Last 30 days (3070)
Last 365 days (32808)
2026 (6826)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (95)
Alaska (7)
Arizona (360)
Arkansas (15)
Asia (51750)
Australia (9096)
California (12422)
Canada (3532)
China (1259)
Colorado (525)
Connecticut (548)
Delaware (371)
Europe (119141)
Florida (1850)
Georgia (401)
Hawaii (4)
Idaho (68)
Illinois (1039)
India (83)
Indiana (584)
Iowa (24)
Japan (479)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1546)
Massachusetts (9125)
Michigan (381)
Minnesota (700)
Mississippi (7)
Missouri (150)
Montana (37)
Nebraska (30)
Nevada (138)
New Hampshire (89)
New Jersey (3339)
New Mexico (33)
New York (3276)
North Carolina (1706)
North Dakota (10)
Northern California (6021)
Ohio (382)
Oklahoma (23)
Oregon (54)
Pennsylvania (2476)
Puerto Rico (25)
Rhode Island (53)
South America (1667)
South Carolina (73)
South Dakota (1)
Southern California (4823)
Tennessee (198)
Texas (1966)
United States (44710)
Utah (375)
Vermont (1)
Virginia (316)
Washington D.C. (88)
Washington State (1026)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 874,498 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
BioMarin Pauses Dosing, Enrollment in 2 Voxzogo Studies After Safety Signal
With Ascendis Pharma entering the achondroplasia space last month and BridgeBio on deck, BioMarin faces competition. Adding to the pressure, the company suffered a setback Monday when it halted two studies of Voxzogo in other growth-related conditions following multiple cases of hip injuries in other trials of the drug.
March 16, 2026
·
2 min read
·
Heather McKenzie
Press Releases
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
March 16, 2026
·
10 min read
Press Releases
Extendicare Announces March 2026 Dividend of C$0.0441 per Share
March 16, 2026
·
2 min read
Press Releases
Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
March 16, 2026
·
13 min read
Press Releases
Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth
March 16, 2026
·
15 min read
Press Releases
George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement
March 16, 2026
·
7 min read
Press Releases
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
March 16, 2026
·
5 min read
Press Releases
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
March 16, 2026
·
9 min read
Press Releases
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
March 16, 2026
·
11 min read
Press Releases
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
March 16, 2026
·
9 min read
1 of 87,450
Next
